Approvals/TGA/YVETTE drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack

Approved

STANDARD

YVETTE drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack

Bayer Australia Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8a19d6aa3fa380bb
Product Name: YVETTE drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack
Artg Id: 226243
Artg Name: YVETTE drospirenone 3mg / ethinylestradiol 20 micrograms (as betadex clathrate) tablet blister pack
Sponsor: Bayer Australia Ltd
Company Detail Path: /organization/bayer-australia-ltd
Artg Date: 2014-08-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

8a19d6aa3fa380bb

Type

Standard